Search Results - "Donat, Sherri M"

Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline by Donat, Sherri M, Diaz, Mireya, Bishoff, Jay Todd, Coleman, Jonathan A, Dahm, Philipp, Derweesh, Ithaar H, Herrell, 3rd, S Duke, Hilton, Susan, Jonasch, Eric, Lin, Daniel W, Reuter, Victor E, Chang, Sam S

“…The purpose of this guideline is to provide a clinical framework for follow-up of clinically localized renal neoplasms undergoing active surveillance, or…”
Get more information

Bacillus Calmette-Guérin Without Maintenance Therapy for High-Risk Non–Muscle-Invasive Bladder Cancer by Herr, Harry W, Dalbagni, Guido, Donat, Sherri M

“…Abstract Background Bacillus Calmette-Guérin (BCG) is the standard intravesical treatment of high-risk noninvasive (Ta, T1, Tis) bladder cancer. Maintenance…”
Get full text

Intraoperative Ureteral Stent Use at Radical Cystectomy is Associated with Higher 30-Day Complication Rates by Donat, Sherri M, Tan, Kay See, Jibara, Ghalib, Dalbagni, Guido, Carlon, Vittoria Arslan, Sandhu, Jaspreet

“…Radical cystectomy/urinary diversion is a high risk procedure. Intraoperative stents are commonly utilized to decrease ureteroenteric anastomosis related…”
Get full text

Evaluation of Women With a Positive Urine Cytology and no Demonstrable Disease in the Urinary Tract by Donat, Sherri M., Sonoda, Yukio, Al-Ahmadie, Hikmat, Murali, Rajmohan, Ng, Dianna L., Funt, Samuel A., Park, Kay J.

“…Urinary cytology is indispensable both for the evaluation of gross hematuria and surveillance of patients with urothelial neoplasms. A positive urine cytology…”
Get full text

Reduced bladder tumour recurrence rate associated with narrow‐band imaging surveillance cystoscopy by Herr, Harry W., Donat, Sherri M.

“…Study Type – Diagnostic (exploratory cohort)
 Level of Evidence 2b What’s known on the subject? and What does the study add? Narrow‐band imaging cystoscopy is…”
Get full text

Association of Biochemically Verified Post-Diagnosis Smoking and Nonmuscle-Invasive Bladder Cancer Recurrence Risk by Furberg, Helena, Petruzella, Stacey, Whiting, Karissa, Stein, Emily, Orlow, Irene, Kenney, Jessica, Corrales-Guerrero, Sergio, Benfante, Nicole, Cha, Eugene K, Donahue, Timothy F, Donat, Sherri M, Herr, Harry W, Matulewicz, Richard S, Pietzak, Eugene, Dalbagni, Guido, Ostroff, Jamie, Bochner, Bernard H

“…Our goal was to determine the association between biochemically verified post-diagnosis smoking exposure and nonmuscle-invasive bladder cancer (NMIBC)…”
Get full text

Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma by Teo, Min Yuen, Al-Ahmadie, Hikmat, Seier, Kenneth, Tully, Christopher, Regazzi, Ashley M., Pietzak, Eugene, Solit, David B., Tickoo, Satish, Reuter, Victor, Cha, Eugene K., Herr, Harry, Donahue, Timothy, Donat, Sherri M., Dalbagni, Guido, Bochner, Bernard H., Funt, Samuel, Iyer, Gopakumar V., Bajorin, Dean F., Ostrovnaya, Irina, Rosenberg, Jonathan E.

“…Background Plasmacytoid urothelial carcinoma (PUC) is a rare, aggressive histologic variant of urothelial cancer characterised by a diffuse growth pattern and…”
Get full text

Examining the Accuracy of Self-Reported Smoking-Related Exposure among Recently Diagnosed Nonmuscle Invasive Bladder Cancer Patients by Petruzella, Stacey, Bochner, Bernard H, Kenney, Jessica, Whiting, Karissa, Sadeghi, Keimya, Benfante, Nicole, Cha, Eugene K, Dalbagni, Guido, Donahue, Timothy, Donat, Sherri M, Herr, Harry W, Pietzak, Eugene, Orlow, Irene, Ostroff, Jamie S, Furberg, Helena

“…Cigarette smoking is a risk factor for developing nonmuscle invasive bladder cancer, and continued smoking exposure after diagnosis may increase the likelihood…”
Get full text

A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy by Yamada, Yoshiya, Kollmeier, Marisa A, Pei, Xin, Kan, Chu Cheng, Cohen, Gil'ad N, Donat, Sherri M, Cox, Brett W, Zelefsky, Michael J

“…Abstract Purpose We report the toxicity and biochemical tumor control outcome of a prospective Phase II study using high-dose-rate brachytherapy (HDR) alone as…”
Get full text

Correction: Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma by Teo, Min Yuen, Al-Ahmadie, Hikmat, Seier, Kenneth, Tully, Christopher, Regazzi, Ashley M., Pietzak, Eugene, Solit, David B., Tickoo, Satish, Reuter, Victor, Cha, Eugene K., Herr, Harry, Donahue, Timothy, Donat, Sherri M., Dalbagni, Guido, Bochner, Bernard H., Funt, Samuel, Iyer, Gopakumar V., Bajorin, Dean F., Ostrovnaya, Irina, Rosenberg, Jonathan E.

Get full text

Feasibility of a geriatric comanagement (GERICO) pilot program for patients 75 and older undergoing radical cystectomy by Letica-Kriegel, Allison S., Tin, Amy L., Nash, Garrett M., Benfante, Nicole E., McNeil, Nita, Vickers, Andrew J., Bochner, Bernard, Donat, Sherri M., Goh, Alvin, Dalbagni, Guido, Donahue, Timothy, Cha, Eugene K., Pietzak, Eugene, Herr, Harry, Korc-Grodzicki, Beatriz, Shahrokni, Armin

“…Retrospective studies have shown the beneficial impact of geriatric comanagement (GERICO) on perioperative outcomes of older adults with cancer. We…”
Get full text

Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure by Sternberg, Itay A, Dalbagni, Guido, Chen, Ling Y, Donat, Sherri M, Bochner, Bernard H, Herr, Harry W

“…We report our experience with intravesical gemcitabine for bladder cancer after failed bacillus Calmette-Guérin treatment. We retrospectively reviewed the…”
Get more information

Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer by Raj, Ganesh V, Herr, Harry, Serio, Angel M, Donat, Sherri M, Bochner, Bernard H, Vickers, Andrew J, Dalbagni, Guido

“…Historically patients with recurrent T1 bladder tumors after bacillus Calmette-Guerin have been treated with bladder sparing approaches. Recently a paradigm…”
Get more information

Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy by Teo, Min Yuen, Guercio, Brendan J., Arora, Arshi, Hao, Xueli, Regazzi, Ashley M., Donahue, Timothy, Herr, Harry W., Goh, Alvin C., Cha, Eugene K., Pietzak, Eugene, Donat, Sherri M., Dalbagni, Guido, Bochner, Bernard H., Olgac, Semra, Sarungbam, Judy, Sirintrapun, S. Joseph, Chen, Ying-Bei, Gopalan, Anuradha, Fine, Samson W., Tickoo, Satish K., Reuter, Victor E., Weigelt, Britta, Schultheis, Anne M., Funt, Samuel A., Bajorin, Dean F., Solit, David B., Iyer, Gopa, Ostrovnaya, Irina, Rosenberg, Jonathan E., Al-Ahmadie, Hikmat

“…•In small cell carcinoma of the bladder, neoadjuvant chemotherapy improves survival.•Pathologic response is associated with superior long-term…”
Get full text

Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed for nonmuscle invasive bladder cancer by Sternberg, Itay A, Keren Paz, Gal E, Chen, Ling Y, Herr, Harry W, Donat, Sherri M, Bochner, Bernard H, Dalbagni, Guido

“…We evaluated the usefulness of routine upper tract imaging in patients followed for nonmuscle invasive bladder cancer. A retrospective review of patients…”
Get more information

Assessment of complication and functional outcome reporting in the minimally invasive prostatectomy literature from 2006 to the present by Hakimi, A. Ari, Faleck, David M., Sobey, Steven, Ioffe, Edward, Rabbani, Farhang, Donat, Sherri M., Ghavamian, Reza

“…What's known on the subject? and What does the study add? Minimally invasive approaches to radical prostatectomy have been touted to lead to superior surgical…”
Get full text

Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer Center Contemporary Experience by Bazzi, Wassim M., Kopp, Ryan P., Donahue, Timothy F., Bernstein, Melanie, Russo, Paul, Bochner, Bernard H., Donat, Sherri M., Dalbagni, Guido, Herr, Harry W.

“…Objective. To report our contemporary experience with partial cystectomy after neoadjuvant chemotherapy. Patients and Methods. Retrospective review of patients…”
Get full text

Salvage High-Dose-Rate Brachytherapy for Recurrent Prostate Cancer After Ultra High Intensity Modulated Radiotherapy: Results of a Prospective Study by Morikawa, Lisa K., MD, Zelefsky, Michael J., MD, Cohen, Gil’ad N., MS, DABMP, Zaider, Marco, PhD, Donat, Sherri M., MD, Yamada, Yoshiya, MD

Get full text

PD55-08 INTRA-OPERATIVE URETERAL STENT USE AT RADICAL CYSTECTOMY IS ASSOCIATED WITH HIGHER 30-DAY COMPLICATIONS RATES by Sandhu, Jaspreet, See, Tan Kay, Dalbagni, Guido, Donat, Sherri M.

Get full text

Intra-operative ureteral stent use at radical cystectomy is associated with higher 30-day complications rates by Donat, Sherri M, Tan, Kay See, Jibara, Ghalib, Dalbagni, Guido, Carlon, Vittoria Arslan, Sandhu, Jaspreet

Get full text